Biotech beauty firm Ourself announced on Thursday the appointment of James Hartman to the role of chief executive officer.

Hartman boasts a wealth of experience in aesthetics and the skincare industry spanning three decades.
Prior to joining Ourself, the executive served as chief commercial officer at Alastin Skincare, where the company achieved unprecedented growth in the physician-dispensed skincare market, expanding its customer footprint by 30-fold, under his leadership.

Hartman also held leadership positions at Obagi, Merz Aesthetics and Allergan Aesthetics, as well as serving as president of Hugel Aesthetics, where he oversaw the consecutive approval and commercialization of the firm’s neurotoxin across the U.S., Canada and Australia.

“The board of directors and I are delighted to welcome Jim Hartman as the new CEO of Ourself. His extensive commercial leadership experience and commitment to scientific excellence make Jim the ideal executive to lead Ourself to a prime position in the professional skincare market,” said Lauren Otsuki, founder and chairman of Ourself.

Hartman’s appointment comes at a time when the California-based beauty brand continues to build growth momentum in the medical-professional skincare market.

“I am thrilled and honored to build upon Ourself’s robust scientific foundation as we expand and drive growth within the market. Our patented delivery system promises to revolutionize the skincare industry, breaking free from decades-old technological limitations,” stated Hartman.

“I am excited to collaborate with aesthetic clinicians nationwide to bring this cutting-edge skincare technology to their practice and patients.”

Founded in 2018, Ourself is a topical cosmetic skincare brand that utilizes patented Tiered-Release Vesicles to improve loss of volume, lines and wrinkles, and uneven pigmentation in skin. Ourself developed the first needle-free Lip Filler clinically proven to restore volume by delivering two sizes of hyaluronic acid into the lips, topically.